United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
541.51
+1.48 (0.27%)
Oct 15, 2026, 4:00 PM EDT - Market closed
United Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Sell Maintains $321 → $368 | Sell | Maintains | $321 → $368 | -32.04% | Oct 15, 2026 |
| UBS | UBS | Buy Maintains $725 | Buy | Maintains | $725 | +33.88% | Oct 14, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $685 | Buy | Reiterates | $685 | +26.50% | Oct 12, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $559 | Hold | Reiterates | $559 | +3.23% | Oct 9, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $687 → $710 | Buy | Maintains | $687 → $710 | +31.11% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $677 → $708 | Buy | Maintains | $677 → $708 | +30.75% | Oct 8, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $566 | Hold | Maintains | $566 | +4.52% | Oct 7, 2026 |
| Jefferies | Jefferies | Buy Maintains $704 | Buy | Maintains | $704 | +30.01% | Oct 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.